Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

8 Results
authFullName_s : Michel Attal

Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.

Jean-Luc Harousseau , Herve Avet-Loiseau , Michel Attal , Catherine Charbonnel , Frederic Garban , et al.
Journal of Clinical Oncology, 2009, 27 (34), pp.5720-6. ⟨10.1200/JCO.2008.21.1060⟩
Journal articles hal-00821143v1

Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience

Hervé Avet-Loiseau , Cyrille Hulin , Loic Campion , Philippe Rodon , Gerald Marit , et al.
Journal of Clinical Oncology, 2013, 31 (22), pp.2806--2809. ⟨10.1200/JCO.2012.46.2598⟩
Journal articles hal-01064339v1

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Mauricette Michallet , Quoc-Hung Le , Mohamad Mohty , Thomas Prébet , Franck Nicolini , et al.
Experimental Hematology, 2008, 36 (5), pp.535-44. ⟨10.1016/j.exphem.2008.01.017⟩
Journal articles inserm-00484237v1

Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.

Philippe Moreau , Frédéric Garban , Michel Attal , Mauricette Michallet , Gérald Marit , et al.
Blood, 2008, 112 (9), pp.3914-5. ⟨10.1182/blood-2008-07-168823⟩
Journal articles hal-00821148v1
Image document

Deciphering the chronology of copy number alterations in Multiple Myeloma

Anil Aktas Samur , Stephane Minvielle , Masood Shammas , Mariateresa Fulciniti , Florence Magrangeas , et al.
Blood Cancer Journal, 2019, 9 (4), pp.39. ⟨10.1038/s41408-019-0199-3⟩
Journal articles inserm-02290251v1
Image document

A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients

Florence Magrangeas , Rowan Kuiper , Hervé Avet-Loiseau , Wilfried Gouraud , Catherine Guérin-Charbonnel , et al.
Clinical Cancer Research, 2016, Epub ahead of print. ⟨10.1158/1078-0432.CCR-15-3163⟩
Journal articles inserm-01313506v1

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02

Xavier Leleu , Michel Attal , Bertrand Arnulf , Philippe Moreau , Catherine Traulle , et al.
Blood, 2013, 121 (11), pp.1968--1975. ⟨10.1182/blood-2012-09-452375⟩
Journal articles hal-01064417v1

Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Michel Attal , Valerie Lauwers-Cances , Gerald Marit , Denis Caillot , Philippe Moreau , et al.
New England Journal of Medicine, 2012, 366 (19), pp.1782-91. ⟨10.1056/NEJMoa1114138⟩
Journal articles hal-00852275v1